| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/18/1995 | CA1335256C Occlusive body for administering a physiologically active substance |
| 04/18/1995 | CA1335255C Low ph pharmaceutical compositions of recombinant beta-interferon |
| 04/16/1995 | CA2133271A1 Methods and compositions for the oral delivery of therapeutic agents |
| 04/16/1995 | CA2118200A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/15/1995 | CA2118098A1 Stable liquid preparation of complex vitamin for internal use |
| 04/13/1995 | WO1995009883A1 Multifunctional organic polymers |
| 04/13/1995 | WO1995009692A1 Surfactant, and emulsion cosmetic and liposome each containing the same |
| 04/13/1995 | WO1995009670A1 Disposable dosage unit for iontophoresis-facilitated delivery |
| 04/13/1995 | WO1995009651A1 Improvements in and relating to vaccines |
| 04/13/1995 | WO1995009648A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 04/13/1995 | WO1995009638A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995009618A1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
| 04/13/1995 | WO1995009617A1 Controlled release potassium dosage form |
| 04/13/1995 | WO1995009616A1 Process ii |
| 04/13/1995 | WO1995009615A1 Process i |
| 04/13/1995 | WO1995009614A1 Pharmaceutical composition |
| 04/13/1995 | WO1995009613A1 Controlled release microspheres |
| 04/13/1995 | WO1995009612A1 Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
| 04/13/1995 | WO1995009611A2 Stable protein: phospholipid compositions and methods |
| 04/13/1995 | WO1995009610A1 Liposomes containing particulate materials |
| 04/13/1995 | WO1995009609A1 New emulsion formulation |
| 04/13/1995 | WO1995009608A1 Method of applying an indicia to a fast-dissolving dosage form |
| 04/13/1995 | WO1995009607A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | WO1995009606A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | WO1995009604A1 Methods and compositions for dispensing fragrances |
| 04/13/1995 | WO1995009601A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 04/13/1995 | WO1995009590A1 Absorption enhancers for topical pharmaceutical formulations |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | DE4341139C1 Dimethicone for the treatment of aphthae |
| 04/13/1995 | DE4334600A1 Topical formulation of a solubilised Ginkgo biloba extract |
| 04/13/1995 | DE4334553A1 Liquid pharmaceutical system for cutaneous administration |
| 04/13/1995 | CA2173452A1 Disposable dosage unit for iontophoresis-facilitated delivery |
| 04/13/1995 | CA2173321A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | CA2173111A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | CA2173109A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 04/13/1995 | CA2172738A1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
| 04/13/1995 | CA2172624A1 Controlled release potassium dosage form |
| 04/13/1995 | CA2172143A1 New emulsion formulation |
| 04/13/1995 | CA2169084A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | CA2167413A1 Pharmaceutical composition |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647443A1 Oil in water emulsion usable for the preparation of a cream |
| 04/12/1995 | EP0647258A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 04/12/1995 | EP0647144A1 Vaginal discharge collection and drug delivery device |
| 04/12/1995 | EP0647133A1 Compositions and methods for enhanced drug delivery |
| 04/12/1995 | EP0647132A1 Galenic composition for topical use. |
| 04/12/1995 | EP0647131A1 Dermatological agent for aiding oxygen transport in the skin. |
| 04/12/1995 | EP0647130A1 Method of hemodialysis and hemodialysis liquids including hydrochloric acid |
| 04/12/1995 | EP0647129A1 Topical application composition. |
| 04/12/1995 | EP0594698B1 Liquid deodorant compositions |
| 04/12/1995 | EP0553241B1 Use of fatty alcohol based compositions for preparing emulsions, method of preparing emulsions and emulsions so obtained |
| 04/12/1995 | EP0511234B1 Stable injectible solutions for factor viii |
| 04/12/1995 | EP0502042B1 Pharmaceutical compositions |
| 04/12/1995 | EP0487520B1 Compressed powder medicaments |
| 04/12/1995 | CN1101280A Wild cypress-seed medicine and its preparation |
| 04/12/1995 | CN1101275A Chinese liquid medicine for curing angiocardiopathy and cerebrovascular diseases and its production |
| 04/12/1995 | CN1101274A Plaster for cough and asthma |
| 04/12/1995 | CN1101272A Medicine for curing gynecopathy such as regulating menstruation, hemostasis and anti-inflammation |
| 04/12/1995 | CN1101268A Prescription and preparation of medicine for child health care - Xiaoer Jianshen San |
| 04/12/1995 | CN1101264A Snakehead oral liquid and its process |
| 04/12/1995 | CN1101257A Chinese medicine acupoint plaster for blood pressure xueya'an |
| 04/11/1995 | USRE34902 Polysiloxane-grafted copolymer non-pressure sensitive topical binder composition and method of coating therewith |
| 04/11/1995 | US5406014 Dehydrogenation processes, equipment and catalyst loads therefor |
| 04/11/1995 | US5405953 Microfibrillated oxycellulose |
| 04/11/1995 | US5405840 Pranoprofen-containing, suspending medicinal composition |
| 04/11/1995 | US5405838 Topical powder compositions containing a cyclic AMP derivative |
| 04/11/1995 | US5405642 Spraying suspension containing dyed filler, solvent and wax into recesses in surface, then removal of excess materials, for visibility and ease of identification |
| 04/11/1995 | US5405628 Feed additive composition for ruminants |
| 04/11/1995 | US5405622 Gamma radiation resistant lubricating gel |
| 04/11/1995 | US5405621 Polymer-coated; administering for treatment of digestive disorders |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | US5405619 Controlled release therapeutic system for liquid pharmaceutical formulations |
| 04/11/1995 | US5405617 Melting stearyl stearate, mixing with drug, spraying melt to coagulate into controlled particle size powder |
| 04/11/1995 | US5405616 Cryopellets; time-releasing agents; used in the field of pharmacy, cosmetics diagnostics, analysis and dietetics |
| 04/11/1995 | US5405615 With aqueous or oil-filled central cavity; useful for delivering dermatological, cosmetic and pharmaceutical formulations |
| 04/11/1995 | US5405614 Electronic transdermal drug delivery system |
| 04/11/1995 | US5405486 Apparatus for forming a transdermal drug device |
| 04/11/1995 | US5405366 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 04/11/1995 | CA2002300C Compositions for the transdermal delivery of pharmaceutical actives |
| 04/11/1995 | CA1335176C Gamma interferon formulation |
| 04/08/1995 | CA2131852A1 Method of making crystalline sugar and products resulting therefrom |
| 04/06/1995 | WO1995009231A1 Insulin-secreting cell lines, methods of production and use |
| 04/06/1995 | WO1995009195A1 Polymer membrane having a high permeability for alkanol |
| 04/06/1995 | WO1995009044A1 Melt granulation with dielectric heating |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1995009008A1 Percutaneously absorbable preparation |
| 04/06/1995 | WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/06/1995 | WO1995009006A1 Monoglyceride/lactate ester permeation enhancer |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995008997A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | WO1995008996A1 Method for treatment of eosinophil-associated conditions |
| 04/06/1995 | WO1995008993A1 Oral formulations of an antifungal |
| 04/06/1995 | WO1995008991A1 Parenteral busulfan for treatment of malignant disease |
| 04/06/1995 | WO1995008988A1 Tablet containing a basic material possibly containing active substances and active substance containing microparticles |
| 04/06/1995 | WO1995008987A1 Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists |
| 04/06/1995 | WO1995008986A1 Camptothecin formulations |
| 04/06/1995 | WO1995008985A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | WO1995008984A1 Aerosol composition for forming a preferably hydrated membrane, preferably hydrated membrane so obtained, and applications thereofparticularly as a dressing |